Top Markets
Coin of the day
GBS Inc. GBS Inc.

GBS Inc.

GBS
Pozycja w akcjach #33721
Operating across North America and the Asia-Pacific region, GBS Inc.... Operating across North America and the Asia-Pacific region, GBS Inc. specializes in biosensor diagnostic technology. Its key product is the Saliva Glucose Biosensor, an innovative organic thin-film transistor designed for diabetes management that quantifies glucose levels directly from saliva. The company is also actively advancing a SARS-CoV-2 Biosensor, intended as a supplementary diagnostic tool to existing RNA virus detection tests, and is constructing a broad biosensor platform covering diagnostic modalities such as biochemistry, immunology, tumor markers, hormones, and nucleic acids. GBS Inc. maintains a research agreement with the Johns Hopkins Bloomberg School of Public Health for the development of saliva-based diagnostic solutions. Founded in 2016 and headquartered in New York, New York, the company adopted its current name, GBS Inc., in September 2019, having previously operated as Glucose Biosensor Systems (Greater China) Holdings, Inc. It operates as a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.
Cena akcji
$0.4732
Ostatnia synchronizacja: 2022-10-26
Kapitalizacja rynkowa
$7.05M
Zmiana (1 dzień)
-0.03%
Zmiana (1 rok)
0.00%
Kraj
US
Handel GBS Inc. (GBS)

Kategoria

Historia ceny akcji dla GBS Inc. (GBS)
Najwyższa cena zamknięcia: $0.49 dnia 2022-10-01

Najniższa cena zamknięcia: $9.14 dnia 2020-12-01
Historia cen akcji firmy GBS Inc. od 2020 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2022 -69.81%
2021 -82.27%
2020 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
$111.15 -15.64%
US
$339.00 -11.24%
US
$91.19 -1.97%
IE
$51.77 -49.83%
US
$91.49 16.90%
US